2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Synovitis: new trials by email Literature Review of Synovitis trials Research Report on Synovitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intensive Replacement Treatment in Haemophilia Patients With Synovitis EHL-FVIII, FVIII concentrate - Hemophilia A | Phase 4 | Completed | Federico II University | 64 | 2022-03-01 | 2024-03-27 |
| Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib Pexidartinib - Tenosynovial Giant Cell Tumor | Phase 4 | Completed | Daiichi Sankyo | 32 | 2020-10-20 | 2024-12-30 |
Giant Cell Tumor of Tendon Sheath (1) · Hemophilia A (1)
Joint Diseases (2) · Musculoskeletal Diseases (2) · Blood Coagulation Disorders (1) · Blood Coagulation Disorders, Inherited (1) · Coagulation Protein Disorders (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Giant Cell Tumors (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Muscular Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Connective Tissue (1)
pexidartinib (1)
Daiichi Sankyo (1) · Federico II University (1)
Italy (2) · Australia (1) · Hungary (1) · Netherlands (1) · Spain (1) · Taiwan (1) · United States (1)